Zetia Wholesalers Denied Class Cert. In Generics-Delay Suit
By Bryan Koenig · April 14, 2022, 7:37 PM EDT
A group of wholesalers accusing Merck and Glenmark Pharmaceuticals of a scheme to delay a generic cholesterol drug are unlikely to force a settlement on the companies after a Virginia federal...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login